Furthermore, the deletion of CCR6 did not lead to decreased numbers of Ki67-positive proliferating cells within intact tumor-bearing mammary glands, pointing to an epithelial-independent function of this receptor in breast cancer. This evidence concerns the gene MKI67 and breast carcinoma.